News
Faricimab, compared with aflibercept, reduces the risk of epiretinal membrane formation in eyes with diabetic macular edema, research shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback